Inventors
Stephen Sunghan Yoo, Ezra Myung Chul Chung, Yong-Sik Bong, Yong-Soo Kim, Andrew H. Park
Assignees
Sctube & Co Inc.
Abstract
Provided herein are molecules having an antigen binding fragment that immuno specifically binds to BTN1A1, such as anti-BTN1A1 antibodies. These molecules include those having an antigen binding fragment that immuno specifically binds to BTN1A1 dimers, such as anti-BTN1A1 dimer antibodies. Methods of making and using these molecules are also provided, including methods of using them in cancer therapies, or as cancer diagnostics.
